Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets

Erik A. Williams; Adrienne J. Werth; Radwa Sharaf; Meagan Montesion; Ethan S. Sokol; Dean C. Pavlick; Molly McLaughlin-Drubin; Rachel Erlich; Helen Toma; Kevin Jon Williams; Jeff M. Venstrom; Brian M. Alexander; Nikunj Shah; Natalie Danziger; Amanda C. Hemmerich; Eric A. Severson; Jonathan Keith Killian; Douglas I. Lin; Jeffrey S. Ross; Julie Y. Tse; Shakti H. Ramkissoon; Mark C. Mochel; Julia A. Elvin

Journal ArticleOPEN ACCESS

Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets

Williams E
Werth A
Sharaf R
et al.

JCO Precision Oncology (2020) (4) 647-661

DOI: 10.1200/po.19.00406

52Citations

40Readers

Abstract

PURPOSEVulvar squamous cell carcinoma (vSCC) encompasses two predominant variants: one associated with detectable high-risk strains of human papillomavirus (hrHPV) and a second form often occurring...

Cite

CITATION STYLE

APA

Williams, E. A., Werth, A. J., Sharaf, R., Montesion, M., Sokol, E. S., Pavlick, D. C., … Elvin, J. A. (2020). Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets. JCO Precision Oncology, (4), 647–661. https://doi.org/10.1200/po.19.00406

Vulvar Squamous Cell Carcinoma: Comprehensive Genomic Profiling of HPV+ Versus HPV– Forms Reveals Distinct Sets of Potentially Actionable Molecular Targets

Abstract

Cite

Register to see more suggestions